UNLOOC

Project Info

In drug development, traditional animal testing faces significant challenges owing to methodological drawbacks and ethical concerns, and often fails to predict human reactions to the drug. The EU-funded UNLOOC project seeks to change this by developing organ-on-chip systems. These innovative devices simulate human organ responses, offering a safer and more reliable testing alternative.

UNLOOC focuses on advancing tools based on engineered cell systems, using AI and enabling high-throughput testing. UNLOOC’s applications will aid academia and the pharmaceutical industry by advancing drug development, enabling cosmetics without animal testing, and supporting personalised medicine. The proposed approach aims to lower costs by up to USD 706 million per new drug, putting Europe at the forefront of this booming field.